The story of Viagra, and its parent company copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in sales , its patent expiration created a flood of lower-priced alternatives , significantly diminishing its market share . While specific businesses may seek to capitalize on similar conditions , the